[{"NetIncomeLoss_4_FY_USD":-182814000.0,"PaymentsToAcquireAvailableForSaleSecuritiesDebt_4_FY_USD":49818000.0,"SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1_0_FY_USD":3.27,"OperatingLeaseExpense_4_FY_USD":1754000.0,"AssetsCurrent_0_FY_USD":323800000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearThree_0_FY_USD":619000.0,"IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_4_FY_USD":-38391000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_4_FY_shares":10471000.0,"StockIssuedDuringPeriodValueNewIssues_4_FY_USD":93279000.0,"NetCashProvidedByUsedInInvestingActivities_4_FY_USD":-6856000.0,"EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_0_FY_USD":56094000.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_FY_USD":3000.0,"SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares_4_FY_shares":4543000.0,"InventoryFinishedGoods_0_FY_USD":4548000.0,"RoyaltyExpense_4_FY_USD":126000.0,"IncomeTaxReconciliationNondeductibleExpense_4_FY_USD":774000.0,"SellingGeneralAndAdministrativeExpense_4_FY_USD":67929000.0,"LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_0_FY_USD":7327000.0,"FinanceLeaseLiabilityNoncurrent_0_FY_USD":3871000.0,"IncomeTaxReconciliationOtherAdjustments_4_FY_USD":1456000.0,"ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions_0_FY_shares":13036.0,"ShareBasedCompensation_4_FY_USD":14794000.0,"OtherComprehensiveIncomeLossNetOfTax_4_FY_USD":-36000.0,"Assets_0_FY_USD":334715000.0,"AvailableForSaleSecuritiesDebtSecurities_0_FY_USD":28239000.0,"CommonStockSharesIssued_0_FY_shares":176883000.0,"UnrecognizedTaxBenefits_0_FY_USD":8230000.0,"ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities_4_FY_USD":43475000.0,"DeferredTaxAssetsTaxCreditCarryforwardsResearch_0_FY_USD":66331000.0,"AdjustmentsToAdditionalPaidInCapitalWarrantIssued_4_FY_USD":14817000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_0_FY_USD":758000.0,"InventoryValuationReserves_0_FY_USD":270000.0,"StockIssuedDuringPeriodValueStockOptionsExercised_4_FY_USD":1814000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_4_FY_shares":14957.0,"CostOfGoodsAndServicesSold_4_FY_USD":1550000.0,"DeferredTaxAssetsOperatingLossCarryforwardsDomestic_0_FY_USD":159939000.0,"SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue_0_FY_USD":4.25,"AccruedLiabilitiesCurrent_0_FY_USD":33942000.0,"DeferredIncomeTaxLiabilities_0_FY_USD":978000.0,"RepaymentsOfLinesOfCredit_4_FY_USD":52420000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_4_FY_USD":-6201000.0,"DeferredTaxLiabilitiesPropertyPlantAndEquipment_0_FY_USD":124000.0,"UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued_0_FY_USD":0.0,"CommonStockValue_0_FY_USD":1769000.0,"IncomeTaxExpenseBenefit_4_FY_USD":0.0,"AccountsReceivableNetCurrent_0_FY_USD":8646000.0,"GainsLossesOnExtinguishmentOfDebt_4_FY_USD":-2011000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_4_FY_shares":167267000.0,"InventoryRawMaterials_0_FY_USD":206000.0,"LesseeOperatingLeaseLiabilityPaymentsDue_0_FY_USD":11165000.0,"ResearchAndDevelopmentExpense_4_FY_USD":122964000.0,"ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions_0_FY_shares":29056.0,"GainLossOnForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments_4_FY_USD":-965000.0,"IncreaseDecreaseInContractWithCustomerLiability_4_FY_USD":-1970000.0,"InterestPayableCurrent_0_FY_USD":21670000.0,"PreferredStockSharesOutstanding_0_FY_shares":0.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearFive_0_FY_USD":582000.0,"DepreciationDepletionAndAmortization_4_FY_USD":748000.0,"LineOfCredit_0_FY_USD":0.0,"IncreaseDecreaseInReceivables_4_FY_USD":-13903000.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_4_FY_USD":-36000.0,"SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_0_FY_shares":16020000.0,"CashAndCashEquivalentsAtCarryingValue_0_FY_USD":272127000.0,"OtherAssetsNoncurrent_0_FY_USD":3802000.0,"IncreaseDecreaseInAccountsPayable_4_FY_USD":17355000.0,"ComprehensiveIncomeNetOfTax_4_FY_USD":-182850000.0,"ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit_4_FY_USD":18.0,"IncreaseDecreaseInInventories_4_FY_USD":7039000.0,"DeferredTaxAssetsOther_0_FY_USD":5563000.0,"CostsAndExpenses_4_FY_USD":192569000.0,"NetCashProvidedByUsedInFinancingActivities_4_FY_USD":302697000.0,"SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1_0_FY_USD":6.14,"IncomeTaxReconciliationChangeInEnactedTaxRate_4_FY_USD":-82000.0,"ProceedsFromLinesOfCredit_4_FY_USD":0.0,"PreferredStockParOrStatedValuePerShare_0_FY_USD":0.01,"ProceedsFromIssuanceOfCommonStock_4_FY_USD":93279000.0,"IncomeTaxReconciliationStateAndLocalIncomeTaxes_4_FY_USD":-2544000.0,"PrepaidExpenseAndOtherAssetsCurrent_0_FY_USD":5528000.0,"InterestExpense_4_FY_USD":14501000.0,"AccountsPayableCurrent_0_FY_USD":18713000.0,"DeferredRevenueCurrent_0_FY_USD":150000.0,"LiabilitiesCurrent_0_FY_USD":105654000.0,"LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_0_FY_USD":1302000.0,"IncreaseDecreaseInDerivativeAssets_4_FY_USD":-632000.0,"PaymentsToAcquireProductiveAssets_4_FY_USD":514000.0,"InventoryWorkInProcess_0_FY_USD":2555000.0,"NetCashProvidedByUsedInOperatingActivities_4_FY_USD":-137216000.0,"ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax_4_FY_USD":1000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_4_FY_USD":14794000.0,"AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_0_FY_USD":6000.0,"AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_0_FY_USD":7336000.0,"AmortizationOfFinancingCosts_4_FY_USD":2428000.0,"IncomeTaxReconciliationForeignIncomeTaxRateDifferential_4_FY_USD":542000.0,"CommonStockSharesOutstanding_0_FY_shares":176883000.0,"ProceedsFromStockOptionsExercised_4_FY_USD":2446000.0,"DefinedContributionPlanEmployerDiscretionaryContributionAmount_4_FY_USD":1569000.0,"NetIncomeLoss_1_FY_USD":-60493000.0,"PropertyPlantAndEquipmentNet_0_FY_USD":7113000.0,"ReceivablesNetCurrent_0_FY_USD":8243000.0,"ProceedsFromIssuanceOfSecuredDebt_4_FY_USD":119867000.0,"LinesOfCreditCurrent_0_FY_USD":0.0,"OperatingLeasePayments_4_FY_USD":1696000.0,"StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_4_FY_USD":632000.0,"AdvertisingExpense_4_FY_USD":6567.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_0_FY_USD":274348000.0,"AdditionalPaidInCapital_0_FY_USD":1002408000.0,"OperatingLeaseWeightedAverageDiscountRatePercent_0_FY_pure":0.127,"EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_4_FY_pure":0.21,"InterestExpenseDebt_4_FY_USD":14501000.0,"OtherAccruedLiabilitiesCurrent_0_FY_USD":4896000.0,"LongTermDebtNoncurrent_0_FY_USD":119735000.0,"UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions_4_FY_USD":1020000.0,"DeferredTaxAssetsGross_0_FY_USD":271734000.0,"IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_4_FY_USD":38551000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_4_FY_USD":158625000.0,"EmployeeRelatedLiabilitiesCurrent_0_FY_USD":11030000.0,"LiabilitiesAndStockholdersEquity_0_FY_USD":334715000.0,"PreferredStockValue_0_FY_USD":0.0,"IncreaseDecreaseInInterestPayableNet_4_FY_USD":6766000.0,"InventoryNet_0_FY_USD":7039000.0,"AvailableForSaleSecuritiesDebtSecuritiesCurrent_0_FY_USD":28239000.0,"NotesPayableCurrent_0_FY_USD":30000000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_4_FY_USD":-182814000.0,"OperatingIncomeLoss_4_FY_USD":-174757000.0,"CommonStockSharesAuthorized_0_FY_shares":450000000.0,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_4_FY_USD":2140000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearFour_0_FY_USD":577000.0,"LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_0_FY_USD":6115000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_4_FY_USD":4.69,"CommonStockParOrStatedValuePerShare_0_FY_USD":0.01,"PreferredStockSharesAuthorized_0_FY_shares":5000000.0,"AllocatedShareBasedCompensationExpense_4_FY_USD":14794000.0,"ProceedsFromIssuanceOfWarrants_4_FY_USD":14817000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_4_FY_shares":1596000.0,"RetainedEarningsAccumulatedDeficit_0_FY_USD":-1023442000.0,"SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue_4_FY_USD":4.12,"TaxesPayableCurrent_0_FY_USD":80000.0,"RevenueFromContractWithCustomerIncludingAssessedTax_1_FY_USD":4016000.0,"RevenueFromContractWithCustomerIncludingAssessedTax_4_FY_USD":17812000.0,"DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_0_FY_USD":10732000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_4_FY_USD":-176613000.0,"AccruedProfessionalFeesCurrent_0_FY_USD":333000.0,"AvailableForSaleDebtSecuritiesAmortizedCostBasis_0_FY_USD":28211000.0,"StockholdersEquity_0_FY_USD":-19262000.0,"FinanceLeaseLiabilityCurrent_0_FY_USD":1179000.0,"EarningsPerShareBasicAndDiluted_1_FY_USD":-0.34,"EarningsPerShareBasicAndDiluted_4_FY_USD":-1.09,"RestrictedCashAndCashEquivalentsAtCarryingValue_0_FY_USD":2221000.0,"PropertyPlantAndEquipmentGross_0_FY_USD":14449000.0,"DeferredTaxAssetsValuationAllowance_0_FY_USD":270756000.0,"SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue_4_FY_USD":3.96,"IncomeTaxReconciliationTaxCreditsResearch_4_FY_USD":4080000.0,"Ticker":"BCRX","CIK":"882796","name":"BIOCRYST PHARMACEUTICALS INC","OfficialName":"BioCryst Pharmaceuticals Inc. Common Stock","form":"10-K","period":"20201231","fy":"2020.0","fp":"FY","qtrs":"4","uom":"USD","footnote":"nan","Market Cap":"1887243586.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Biological Products (No Diagnostic Substances)","Market":"NASDAQ","SP500":"nan","filed":"20210301"}]